Beam Therapeutics (BEAM) Asset Utilization Ratio (2020 - 2026)

Beam Therapeutics (BEAM) has reported Asset Utilization Ratio for 7 consecutive years, with 0.11 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 123.89% year-over-year to 0.11; the TTM figure through Mar 2026 stood at 0.11 (up 123.89% YoY), while the FY2025 annual figure was 0.11, up 118.18% from the prior year.
• Asset Utilization Ratio climbed to 0.11 in Q1 2026 per BEAM's latest filing, from 0.1 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.29 in Q3 2024 and bottomed at 0.04 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.11 across 5 years, with a median of 0.06 in 2023.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 176929.34% — and 2025, when it plunged 85.66%.
• Beam Therapeutics' Asset Utilization Ratio stood at 0.05 in 2022, then jumped by 506.87% to 0.27 in 2023, then slumped by 79.67% to 0.06 in 2024, then jumped by 79.27% to 0.1 in 2025, then increased by 10.64% to 0.11 in 2026.
• Business Quant data shows BEAM's Asset Utilization Ratio at 0.11 in Q1 2026, 0.1 in Q4 2025, and 0.04 in Q3 2025.